Ebrahim Adamjee
Dr. Ebrahim Adamjee is a Kenyan physician and health-systems strategist whose work bridges clinical practice, industry innovation, and capacity-building across Sub-Saharan Africa. A graduate of the University of Nairobi (MBChB) with a master’s in Health Economics & Pharmacoeconomics from the Barcelona School of Management, he has spent more than a decade in medical-affairs leadership roles at global pharma companies, advising ministries of health and frontline providers on evidence-based care.
As Medical Lead for Transplant & Immunology at Novartis East Africa, Dr. Adamjee designed and launched INTERLIFE, the public-private partnership that transformed Kenyatta National Hospital into a regional kidney-transplant hub. Since 2019 the programme has trained more than 200 surgeons, nephrologists, nurses, and pharmacists; introduced electronic immunosuppression protocols that halved rejection rates; and enabled over 350 successful live-donor transplants for patients who previously had to travel abroad.
Beyond transplantation, he has guided heart-failure and sickle-cell disease access programmes in Tanzania, Zambia, and Ethiopia, integrating cost-effective therapies into national formularies. A recognised voice on value-based healthcare, Dr Adamjee speaks at ISPOR Africa and serves on Kenya’s National Medicines & Therapeutics Committee, advocating for pharmaco-economic data in reimbursement decisions.
He mentors clinical entrepreneurs through Villgro Africa, sits on the board of the Renal Patients Society of Kenya, and writes on health-technology assessment for the East African Medical Journal. His mission is clear: build resilient, data-driven health systems that deliver world-class care close to home.